Esserre Pharma, a company that operates in the field of nutraceuticals strictly using products “Made in Italy”, is among the 450 Italian companies that have grown the most in a ranking according to Il Sole 24 Ore and Statista.


The unstoppable rise of Esserre Pharma continues, a nutraceutical company focused on the potential and enhancement of the Italian territory, which offers products based on bergamot and Mediterranean extracts, with a focus on green and sustainable globalization.

The company was included among the top growth leaders of 2022 according to the ranking of Il Sole 24 Ore and Statista, which groups together the 450 Italian companies that recorded the greatest growth in revenue between 2017 and 2020.

The list, based on the average annual growth rate over the three-year period, and now in its fourth year, does not include large multinationals but rather small companies that are potentially relevant and capable of competing at a European level. Esserre Pharma, founded in 2013 and now present in 28 countries around the world with 5 product lines, ranked 73rd out of 450 companies in the 2022 Growth Leader ranking!

An excellent result, which rewards the choice of producing nutraceuticals exclusively from a fully traceable Italian supply chain, thus giving value to the territory while offering innovative solutions, with the aim of improving the quality of life.

Esserre Pharma not only has the goal of making the most of Mediterranean products, but also subjects them to careful scientific research in order to ensure their correct transformation into nutraceuticals. The quality of the raw materials, selected according to strict regulations as well as that of the final product, is one of the company’s top priorities.

As one example, Esserre Pharma has carried out scientific research on the lipid-lowering properties of bergamot, an extraordinary citrus fruit that was used only by the essential oil and perfume industry for many years, while the internal parts and juice were considered waste material. Based on research and innovative know-how, in 2014 Esserre Pharma launched its first product, ColBer®, a nutraceutical based on bergamot flavonoids, and containing a titrated extract of artichoke leaves, phytosterols, and vitamin C. ColBer® is able to modulate cholesterol, triglycerides, and blood sugar.

The company, which obtained ISO 9001:2015 certification in March 2020, is now expanding its presence in the international market by exporting and making the potential benefits of Mediterranean products known to all around the world.